Document Detail


CYP2C9*3 Loss-of-Function Allele Is Associated With Acute Upper Gastrointestinal Bleeding Related to the Use of NSAIDs Other Than Aspirin.
MedLine Citation:
PMID:  20445534     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Nonsteroidal anti-inflammatory drugs (NSAIDs), other than aspirin, are to some extent metabolized by cytochrome P450 2C9 (CYP2C9). The CYP2C9 359Leu (CYP2C9*3) loss-of-function allele could be a risk factor for acute upper gastrointestinal bleeding (AUGIB) related to the use of NSAIDs other than aspirin. To test this hypothesis, we performed a prospective, multicenter, case-case study in patients hospitalized for AUGIB related to the use of NSAIDs. A total of 131 patients had been treated with aspirin and 57 patients had been treated with an NSAID other than aspirin (non-ASP). In the aspirin group, 12 patients (9.2%) had the CYP2C9 359Leu allele as compared with 19 (33.3%) in the non-ASP group (odds ratio (OR) = 5.0; 95% confidence interval 2.2-11.1, P < 0.0001). In a multivariate analysis, CYP2C9 359Leu remained associated with the non-ASP group (OR = 7.2 (2.6-20.3), P = 0.0002) even though 40% of these patients were under treatment with antiulcer drugs at the time of admission. Therefore the results of the study support the hypothesis that the CYP2C9 359Leu allele is a robust risk factor for AUGIB related to the use of NSAIDs other than aspirin.
Authors:
N Carbonell; C Verstuyft; J Massard; A Letierce; C Cellier; L Deforges; F Saliba; J C Delchier; L Becquemont
Related Documents :
20621074 - Pivka-ii is a candidate marker for monitoring the effects of the oral anticoagulant war...
18477734 - Aspirin, clopidogrel, and warfarin: is the combination appropriate and effective or ina...
17175564 - A randomised controlled trial of warfarin versus aspirin for stroke prevention in octog...
10325554 - Aspirin intolerance in patients with chronic sinusitis.
12141204 - Aponeurotic repair of involutional blepharoptosis.
10942744 - Randomized, double-blind trial of simultaneous right and left atrial epicardial pacing ...
Publication Detail:
Type:  Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't     Date:  2010-05-05
Journal Detail:
Title:  Clinical pharmacology and therapeutics     Volume:  87     ISSN:  1532-6535     ISO Abbreviation:  Clin. Pharmacol. Ther.     Publication Date:  2010 Jun 
Date Detail:
Created Date:  2010-05-20     Completed Date:  2010-06-03     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  0372741     Medline TA:  Clin Pharmacol Ther     Country:  United States    
Other Details:
Languages:  eng     Pagination:  693-8     Citation Subset:  AIM; IM    
Affiliation:
Hepatology Department, Assistance Publique H?pitaux de Paris, Saint-Antoine Hospital, University Pierre et Marie Curie, Paris, France.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Aged
Aged, 80 and over
Alleles
Anti-Inflammatory Agents, Non-Steroidal / adverse effects*,  metabolism
Anti-Ulcer Agents / therapeutic use
Aryl Hydrocarbon Hydroxylases / genetics*
Aspirin / adverse effects*
Case-Control Studies
Female
Gastrointestinal Hemorrhage / chemically induced*,  genetics
Humans
Male
Middle Aged
Multivariate Analysis
Prospective Studies
Risk Factors
Chemical
Reg. No./Substance:
0/Anti-Inflammatory Agents, Non-Steroidal; 0/Anti-Ulcer Agents; 50-78-2/Aspirin; EC 1.14.14.1/Aryl Hydrocarbon Hydroxylases; EC 1.14.14.1/CYP2C9 protein, human

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Role of RAS Inhibition in the Regulation of Cu/Zn-SOD in the Cardiac and Peripheral Arterial Beds in...
Next Document:  Significant Increase in Systemic Exposure of Atorvastatin After Biliopancreatic Diversion With Duode...